Results 211 to 220 of about 73,935 (281)

On why cancer cells require a great amount of glucose

open access: yesQuantitative Biology, Volume 14, Issue 2, June 2026.
Abstract The traditional thinking has been that cancer cells require a great amount of glucose to support their rapid growth, but the reality may be different. We have previously demonstrated that all cancer cells in The Cancer Genome Atlas harbor persistent Fenton reactions in their cytosol, which generate OH− ${\text{OH}}^{-}$ and ultimately kill the
Xuechen Mu   +6 more
wiley   +1 more source

One‐Pot Amidation/C─H Halogenation by an Efficient Electrochemical Cascade

open access: yesAngewandte Chemie, Volume 138, Issue 19, 4 May 2026.
A sustainable electrochemical cascade enables the one‐pot synthesis of regioselectively halogenated N‐aryl amides from readily available amines and acyl halides under mild conditions. The method merges amidation and C─H halogenation in a single operational step, delivering broad substrate scope, high selectivity, and scalability, and provides an ...
Sudipta Ponra   +8 more
wiley   +2 more sources

Merging Micellar Catalysis and C–H Activation: Silver‐Free Direct Arylation of Fluoroarenes in Water

open access: yesChemSusChem, Volume 19, Issue 9, 14 May 2026.
We have developed the first silver‐free protocol for a palladium‐catalyzed direct arylation in water under micellar conditions enabling the coupling of diverse pyridine and fluoroarene derivatives. This method combines the sustainability of aqueous media with the efficiency of C–H activation, obviating the need for organic co‐solvents or stoichiometric
Federico Belnome   +9 more
wiley   +1 more source

Metabolism of Epigenetic Ribonucleosides Leads to Nucleolar Stress and Cytotoxicity. [PDF]

open access: yesACS Chem Biol
Sun X   +8 more
europepmc   +1 more source

Boron Neutron Capture Therapy at a Crossroads: Translational Gap and Emerging Delivery Agents

open access: yesChemistry – A European Journal, Volume 32, Issue 17, 5 May 2026.
This review surveys recent advances in boron delivery agents for BNCT, emphasizing the shift from classical small molecules to multifunctional nanocarriers and theranostic systems. By integrating targeting, imaging, and therapy, next‐generation boron compounds aim to bridge the gap between (bio)chemical innovation and clinical translation.
Christoph Selg, Evamarie Hey‐Hawkins
wiley   +1 more source

Home - About - Disclaimer - Privacy